Paris, France-based medical device company EOS imaging reported its consolidated sales and revenue for the fourth quarter and full year 2017. EOS imaging recorded annual revenue of $45.4 million, up 21 percent compared to the full year 2016.
Here are six things to know:
1. EOS imaging develops and markets EOS, a medical imaging system dedicated to osteoarticular pathologies and orthopedics. The company is authorized to market in 51 countries, including the U.S., Japan and the European Union.
2. The company sold 77 EOS systems in 2017, compared to 60 in the same period last year. Revenue from equipment sales was $36.7 million, up 20 percent compared to 2016.
3. The company delivered top-line growth in 2017 and significantly reshaped its presence in North America, its most strategic market. North American sales increased by 53 percent in the fourth quarter. For the whole year, sales amounted to $17.9 million and represented 39 percent of total sales, compared with 50 percent in 2016.
4. Asia Pacific sales grew 83 percent to $7.2 million, notably due to the China and Australia markets. EOS imaging's sales in Europe, Middle East and Africa grew 45 percent to $20.3 million and accounted for 45 percent of the company’s sales, compared to 37 percent in 2016. There was no sale in Latin America, which was not a priority area of exploration.
5. Excluding Latin America, full year revenue increased 24 percent and forth quarter revenue increased 32 percent or 35 percent at constant exchange rate.
6. Sales in the last quarter amounted to $14.9 million, up 22 percent from the fourth quarter of 2016.
More articles on imaging:
Santa Rosa Orthopaedics installs new robotic surgery system: 4 highlights
Johns Hopkins image-guided robot performs 1st spinal screw insertion: 5 observations